Clonazepam
کلونازپام
🧠 Nervous SystemBenzodiazepine
Market / country: 🇺🇸 USA
Klonopin (US) · Rivotril (GB)
🧮 Dose calculator
Epilepsy (complex partial / absence seizures) · Regimen source: FDA Clonazepam · Dosage and Administration
- • Increase by no more than 0.25–0.5 mg every 3 days to maintenance 0.1–0.2 mg/kg/day in three doses. FDA Clonazepam · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Sensitivity to benzodiazepines; significant liver disease; acute narrow-angle glaucoma. FDA Clonazepam · Contraindications
Warnings
- • Boxed warning: concomitant opioids (respiratory depression, coma, death); abuse, misuse, addiction and dependence. FDA Clonazepam · WARNING (boxed)
Formulations
- 0.5 mg tablet (scored) — tablet 🇺🇸 USA FDA Clonazepam · How Supplied
- 2 mg tablet (scored) — tablet 🇺🇸 USA FDA Clonazepam · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Clonazepam · Pregnancy:
“Risk Summary Neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal (see WARNINGS: Neonatal Sedation and Withdrawal Syndrome , and Clinical Considerations ).”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Clonazepam · Nursing Mothers:
“Risk Summary Clonazepam is excreted in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Clonazepam · Precautions/Warnings – Pediatric Use
“Because of the possibility that adverse effects on physical or mental development could become apparent only after many years, a benefit-risk consideration of the long-term use of clonazepam tablets is important in pediatric patients being treated for seizure disorder (see INDICATIONS AND USAGE and”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Clonazepam · Precautions/Warnings – Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA075150
- DailyMed (FDA label)FDA Clonazepam
- MedlinePlus (NIH)Clonazepam
- WHO ATC/DDDN03AE01
- Darooyab (Iran)Clonazepam
🇮🇷 Registered in Iran Darooyab · G-661/Clonazepam
Dosage forms with Iranian generic codes, per Darooyab.
- 10928 · CLONAZEPAM 0.5MG TAB · قرص کلونازپام ۰٫۵ میلیگرم
- 00322 · CLONAZEPAM 1MG TAB · قرص کلونازپام ۱ میلیگرم
- 00323 · CLONAZEPAM 2MG TAB · قرص کلونازپام ۲ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Clonazepam · How SuppliedFDA Clonazepam · Dosage and AdministrationFDA Clonazepam · ContraindicationsFDA Clonazepam · WARNING (boxed)FDA Clonazepam · Pregnancy:FDA Clonazepam · Nursing Mothers:FDA Clonazepam · Precautions/Warnings – Pediatric UseFDA Clonazepam · Precautions/Warnings – Geriatric UseFDA Clonazepam · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-661/Clonazepam
- Clinical review⚠ Unverified